CD1a and bound lipids drive T‐cell responses in human skin disease

Abstract

AbstractIn addition to serving as the main physical barrier with the outside world, human skin is abundantly infiltrated with resident αβ T cells that respond differently to self, infectious, microbiome, and noxious stimuli.  To study skin T cells during infection and inflammation, experimental biologists track T‐cell surface phenotypes and effector functions, which are often interpreted with the untested assumption that MHC proteins and peptide antigens drive measured responses.  However, a broader perspective is that CD1 proteins also activate human T cells, and in skin, Langerhans cells (LCs) are abundant antigen presenting cells that express extremely high levels of CD1a.  The emergence of new experimental tools, including CD1a tetramers carrying endogenous lipids, now show that CD1a‐reactive T cells comprise a large population of resident T cells in human skin.  Here, we review studies showing that skin‐derived αβ T cells directly recognize CD1a proteins, and certain bound lipids, such as contact dermatitis allergens, trigger T‐cell responses. Other natural skin lipids inhibit CD1a‐mediated T‐cell responses, providing an entry point for the development of therapeutic lipids that block T‐cell responses. Increasing evidence points to a distinct role of CD1a in type 2 and 22 T‐cell responses, providing new insights into psoriasis, contact dermatitis, and other T‐cell‐mediated skin diseases.